razoxane has been researched along with Esophagitis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Byfield, JE; Clamon, GH; Corder, MP; Herbst, KD; Leimert, JT; Platz, CE; Tewfik, HH | 1 |
| Bush, H; Hellmann, K; James, SE; Spittle, MF | 1 |
2 trial(s) available for razoxane and Esophagitis
| Article | Year |
|---|---|
Radiotherapy plus razoxane for advanced limited extent carcinoma of the lung.
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Blood Cell Count; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Child; Child, Preschool; Clinical Trials as Topic; Combined Modality Therapy; Drug Administration Schedule; Esophagitis; Female; Humans; Lung Neoplasms; Male; Middle Aged; Piperazines; Pneumonia; Radiation Injuries; Random Allocation; Razoxane | 1984 |
Clinical trial of razoxane and radiotherapy for inoperable carcinoma of the bronchus.
Topics: Bronchial Neoplasms; Carcinoma, Small Cell; Clinical Trials as Topic; Esophagitis; Humans; Leukopenia; Piperazines; Radiation Injuries; Radiotherapy, High-Energy; Razoxane | 1979 |